N-Desmethylclozapine is primarily used as the major active metabolite of the atypical antipsychotic clozapine; it acts as a potent allosteric partial agonist at M1 muscarinic receptors (EC50 = 115 nM), enhancing hippocampal N-methyl-D-aspartate (NMDA) receptor currents via M1 receptor activation; it also functions as a δ-opioid receptor agonist; exhibits slight agonistic effects on M1 mAChRs and 5-HT1A receptors in the cerebral cortex and hippocampus; suppresses K+ channels via M1 receptors in excitatory neurons; modulates thromboxane B2 (TxB2) levels under both unstimulated and TSST-1-stimulated conditions, suggesting potential effects on neurotransmitter systems through regulation of TxA2/TxB2 production; demonstrates antiviral activity against DENV-2 in Huh-7 cells by reducing viral NS3 protein and negative-strand RNA levels; shows species- and receptor subtype-specific effects at M2 and M4 mAChRs involved in presynaptic modulation of GABA and glutamate release.